Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03833050 · ClinicalTrials.gov registry record
The TOGETHER Project - Heart
A clinical trial of Heart Transplant Rejection, sponsored by Mayo Clinic.
- Completed
- Registry status
- 101
- Enrollment target
- 3
- Study locations
NCT03833050: Completed study of Heart Transplant Rejection, sponsored by Mayo Clinic.
NCT03833050 is a study of Heart Transplant Rejection that has completed, run by Mayo Clinic. The registered enrollment target is 101 participants, below the 721-participant average among 5 other Heart Transplant Rejection trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03833050, a study of Heart Transplant Rejection, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
- 3
- Study locations
Study Summary
The researchers are trying to develop a way to measure the risk of transplant rejection with a blood test.
Primary Outcome
Cases will be reviewed and a subset of the peripheral blood specimens will be sent to Mayo Clinic Laboratories for development of the RNA-seq signature. The number of specimens analyzed will be determined based on the incidence of rejection and the incidence of biopsies for cause needed to develop the signature.
Conditions Studied
Study Locations (3)
Arizona
- Mayo Clinic - Phoenix
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2017-12-07 |
| Est. Completion | 2020-09-22 |
What the finished NCT03833050 record still lists
NCT03833050 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 721-participant average among 5 other Heart Transplant Rejection trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Heart Transplant Rejection appearing as the primary indexed condition, and to 0 interventions.
NCT03833050 reports a single indexed study location in Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03833050 about?
NCT03833050 is a clinical study titled "The TOGETHER Project - Heart". The researchers are trying to develop a way to measure the risk of transplant rejection with a blood test.
What is the current status of trial NCT03833050?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2017-12-07. Estimated completion is 2020-09-22.
What conditions does trial NCT03833050 study?
This clinical trial studies the following conditions: Heart Transplant Rejection.
Who is sponsoring clinical trial NCT03833050?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03833050 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Transplant Rejection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Trifecta-Heart cfDNA-MMDx Study
RECRUITING
-
Prospera Test Evaluation in Cardiac Transplant (ProTECT)
ACTIVE NOT RECRUITING
-
Surveillance HeartCare® Outcomes Registry
ACTIVE NOT RECRUITING
-
Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI